These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 11606141

  • 1. Synthesis and cytotoxicity on sensitive and doxorubicin-resistant cell lines of new pyrrolo[2,1-c][1,4]benzodiazepines related to anthramycin.
    Langlois N, Rojas-Rousseau A, Gaspard C, Werner GH, Darro F, Kiss R.
    J Med Chem; 2001 Oct 25; 44(22):3754-7. PubMed ID: 11606141
    [Abstract] [Full Text] [Related]

  • 2. [Research on agents with antineoplastic activity. LXIII. Anthramycin and analogous compounds. X. Synthesis of 11-phenyl-5H-pyrrolo[2,1-c] [1,4] benzodiazepine derivatives].
    Porretta GC, Scicchitano G, Filacchioni G, Scalzo M, Artico M.
    Farmaco Sci; 1979 Oct 25; 34(10):914-22. PubMed ID: 510534
    [Abstract] [Full Text] [Related]

  • 3. [Study on substances with antiblastic activity. LIX - Anthramycin and analogs. VIII : synthesis of derivatives of 4H-pyrrolo/1,2-a/[1,5]benzodiazepine].
    Chimenti F, Vomero S, Giuliano R, Artico TM.
    Farmaco Sci; 1977 May 25; 32(5):339-47. PubMed ID: 862889
    [Abstract] [Full Text] [Related]

  • 4. Usabamycins A-C: new anthramycin-type analogues from a marine-derived actinomycete.
    Sato S, Iwata F, Yamada S, Kawahara H, Katayama M.
    Bioorg Med Chem Lett; 2011 Dec 01; 21(23):7099-101. PubMed ID: 22001031
    [Abstract] [Full Text] [Related]

  • 5. Porothramycin, a new antibiotic of the anthramycin group: production, isolation, structure and biological activity.
    Tsunakawa M, Kamei H, Konishi M, Miyaki T, Oki T, Kawaguchi H.
    J Antibiot (Tokyo); 1988 Oct 01; 41(10):1366-73. PubMed ID: 3192492
    [Abstract] [Full Text] [Related]

  • 6. Heterocyclic analogs of DNA minor groove alkylating agents.
    Baraldi PG, Cacciari B, Guiotto A, Romagnoli R, Zaid AN, Spalluto G.
    Curr Pharm Des; 1998 Jun 01; 4(3):249-76. PubMed ID: 10197042
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and in Vitro cytotoxic activities of 2-alkyl-2,3-dihydro-1H-2,6-diazacyclopenta[b]anthracene-5,10-diones.
    Kwak JH, Namgoong K, Jung JK, Han SB, Cho J, Kim HM, Park SG, Lee K, Kang JS, Lee H.
    Arch Pharm Res; 2010 May 01; 33(5):663-7. PubMed ID: 20512462
    [Abstract] [Full Text] [Related]

  • 8. [Studies on substances with antiblastic activity. IX. Anthramycin and analogs. IX. Synthesis of 7-methoxy-8-hydroxy-10,11-dihydro-5H-pyrrolo[2,1-c] [1,4] benzodiazepine and other compounds related to oxotomaymycin].
    Scalzo M, Artico M, Giuliano R, Chimenti F, Vomero S, Nacci V.
    Farmaco Sci; 1977 Aug 01; 32(8):579-92. PubMed ID: 891911
    [Abstract] [Full Text] [Related]

  • 9. Effect of A-ring modifications on the DNA-binding behavior and cytotoxicity of pyrrolo[2,1-c][1,4]benzodiazepines.
    Thurston DE, Bose DS, Howard PW, Jenkins TC, Leoni A, Baraldi PG, Guiotto A, Cacciari B, Kelland LR, Foloppe MP, Rault S.
    J Med Chem; 1999 Jun 03; 42(11):1951-64. PubMed ID: 10354403
    [Abstract] [Full Text] [Related]

  • 10. From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs).
    Mantaj J, Jackson PJ, Rahman KM, Thurston DE.
    Angew Chem Int Ed Engl; 2017 Jan 09; 56(2):462-488. PubMed ID: 27862776
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and cytotoxic evaluation of novel spirohydantoin derivatives of the dihydrothieno[2,3-b]naphtho-4,9-dione system.
    Gomez-Monterrey I, Santelli G, Campiglia P, Califano D, Falasconi F, Pisano C, Vesci L, Lama T, Grieco P, Novellino E.
    J Med Chem; 2005 Feb 24; 48(4):1152-7. PubMed ID: 15715481
    [Abstract] [Full Text] [Related]

  • 12. Fatty acyl amide derivatives of doxorubicin: synthesis and in vitro anticancer activities.
    Chhikara BS, St Jean N, Mandal D, Kumar A, Parang K.
    Eur J Med Chem; 2011 Jun 24; 46(6):2037-42. PubMed ID: 21420207
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
    Kamal A, Ramu R, Tekumalla V, Khanna GB, Barkume MS, Juvekar AS, Zingde SM.
    Bioorg Med Chem; 2007 Nov 15; 15(22):6868-75. PubMed ID: 17822905
    [Abstract] [Full Text] [Related]

  • 14. Effect of C2/C3-endo unsaturation on the cytotoxicity and DNA-binding reactivity of pyrrolo[2,1-c][1,4]benzodiazepines.
    Gregson SJ, Howard PW, Barcella S, Nakamya A, Jenkins TC, Kelland LR, Thurston DE.
    Bioorg Med Chem Lett; 2000 Aug 21; 10(16):1849-51. PubMed ID: 10969983
    [Abstract] [Full Text] [Related]

  • 15. Cellular pharmacology of novel C8-linked anthramycin-based sequence-selective DNA minor groove cross-linking agents.
    Smellie M, Kelland LR, Thurston DE, Souhami RL, Hartley JA.
    Br J Cancer; 1994 Jul 21; 70(1):48-53. PubMed ID: 8018540
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and biological evaluation of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives.
    Shanab K, Schirmer E, Knafl H, Wulz E, Holzer W, Spreitzer H, Schmidt P, Aicher B, Müller G, Günther E.
    Bioorg Med Chem Lett; 2010 Jul 01; 20(13):3950-2. PubMed ID: 20537894
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and cytotoxicity of 6,11-dihydro-pyrido- and 6,11-dihydro-benzo[2,3-b]phenazine-6,11-dione derivatives.
    Kim YS, Park SY, Lee HJ, Suh ME, Schollmeyer D, Lee CO.
    Bioorg Med Chem; 2003 Apr 17; 11(8):1709-14. PubMed ID: 12659757
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxicity of 2,2':6',2' '-terpyridineplatinum(II) complexes against human ovarian carcinoma.
    Lowe G, Droz AS, Vilaivan T, Weaver GW, Park JJ, Pratt JM, Tweedale L, Kelland LR.
    J Med Chem; 1999 Aug 12; 42(16):3167-74. PubMed ID: 10447962
    [Abstract] [Full Text] [Related]

  • 19. Intensely potent doxorubicin analogues: structure-activity relationship.
    Farquhar D, Cherif A, Bakina E, Nelson JA.
    J Med Chem; 1998 Mar 12; 41(6):965-72. PubMed ID: 9526570
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological evaluation of 3-arylisoquinolines as antitumor agents.
    Cho WJ, Park MJ, Chung BH, Lee CO.
    Bioorg Med Chem Lett; 1998 Jan 06; 8(1):41-6. PubMed ID: 9871625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.